Effect of Granulocyte Colony-Stimulating Factor Combination Therapy on Efficacy of Posaconazole (SCH56592) in an Inhalation Model of Murine Pulmonary Aspergillosis

Using an inhalation model of pulmonary aspergillosis, we observed modest differences in the survival rates of mice treated with granulocyte colony-stimulating factor (G-CSF) and posaconazole (POS) and those treated with POS alone. This finding is in contrast to a previous report that suggested that...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Patera, Andriani C., Menzel, Frederick, Jackson, Craig, Brieland, Joan K., Halpern, Judy, Hare, Roberta, Cacciapuoti, Anthony, Loebenberg, David
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2004
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC478512/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15273138/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.8.3154-3158.2004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia